Squarepoint’s Sanofi SNY Stock Holding History

Squarepoint’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,900	Closed	-$383K	–	4915
2025 Q4	$383K	Buy	+7,900	New	+$392K	﹤0.01%	3426
2025 Q1	–	Sell	-42,300	Closed	-$2.04M	–	5347
2024 Q4	$2.04M	Buy	+42,300	New	+$2.15M	﹤0.01%	2395
2024 Q1	–	Sell	-135,000	Closed	-$6.71M	–	4573
2023 Q4	$6.71M	Buy	+135,000	New	+$6.6M	0.01%	1199

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Squarepoint's SNY Position: Q1 2026 in Review

Squarepoint increased its Sanofi (SNY) stake by 239% in Q1 2026, buying an estimated $3.74M and bringing the position to 113,857 shares worth $3.87M. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Squarepoint first reported a position in SNY in Q4 2016 and has held it in 5 quarters since. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Squarepoint held 113,857 shares of Sanofi worth $3.87M as of Q1 2026.
Squarepoint bought 80,291 Sanofi shares in Q1 2026, an estimated $3.74M.
Sanofi made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #1698 holding.
Squarepoint first reported a position in Sanofi in Q4 2016 and has held it in 5 quarters since.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.